Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersFRA:1SP +1.72%61 Equity-to-Asset is 0.21 as of Jun. 2026, which is 11% above its 10-year median of 0.19. GuruFocus rates FRA:1SP with a GF Score™ of 61/100 and a GF Value™ of €21.05 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Surgery Partners ranks worse than 81.22% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Surgery Partners's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €1,450 Mil. Surgery Partners's Total Assets for the quarter that ended in Jun. 2026 was €6,987 Mil.
Therefore, Surgery Partners's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.21.
The historical rank and industry rank for Surgery Partners's Equity-to-Asset or its related term are showing as below:
FRA:1SP'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0 Med: 0.19 Max: 0.31
Current: 0.21
During the past 13 years, the highest Equity to Asset Ratio of Surgery Partners was 0.31. The lowest was 0.00. And the median was 0.19.
FRA:1SP's Equity-to-Asset is ranked worse than 81.22% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs FRA:1SP: 0.21
Surgery Partners (FRA:1SP) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Surgery Partners Equity-to-Asset Related Terms
Surgery Partners Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Surgery Partners's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1SP vs SNDA, ASTH, AGL: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Surgery Partners's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Surgery Partners's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Surgery Partners's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (FRA:1SP) has a Equity-to-Asset of 0.21 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Surgery Partners and its competitors. This is 11% above median its historical median of 0.19. According to the industry distribution chart, Surgery Partners ranks #558 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 81.2%.
Is Surgery Partners' Equity-to-Asset too high?
Surgery Partners' current Equity-to-Asset of 0.21 is 11% above median its 10-year median of 0.19. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Surgery Partners' value of 0.21 is 56.3% below this industry median. Based on the distribution chart, Surgery Partners ranks #558 out of 687 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Surgery Partners has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' Equity-to-Asset compare to SNDA and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #558 out of 687 companies for Equity-to-Asset. This places Surgery Partners in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Surgery Partners' value of 0.21 is 56.3% below this benchmark. While the company's 10-year median is 0.19 vs. the industry median of 0.48, Surgery Partners has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current Equity-to-Asset of 0.21 is 56.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current Equity-to-Asset is 0.21, which is 11% above median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (FRA:1SP) is currently considered Possible Value Trap. The stock's GF Value™ is €21.05, compared to a current price of €11.80 — trading 43.9% below its estimated fair value. The current Equity-to-Asset is 0.21, which is 11% above median its 10-year median of 0.19 and 56.3% below the Healthcare Providers & Services industry median of 0.48. Surgery Partners' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Surgery Partners (FRA:1SP), the current Equity-to-Asset is 0.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (FRA:1SP) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of €11.80 is trading 43.9% below its estimated GF Value™ of €21.05.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for FRA:1SP:
Equity-to-Asset: 0.21 (11% above median its 10-year median of 0.19)
GF Value™: €21.05 vs. price of €11.80 (43.9% below fair value)
Industry Position: 56.3% below the Healthcare Providers & Services median (#558 of 687)
No single metric tells the full story. See the FRA:1SP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
61GF Score
Get the complete analysis for FRA:1SP
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1SP has been successfully added to your 
